Correlation Between 23Andme Holding and Maravai Lifesciences
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Maravai Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Maravai Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Maravai Lifesciences Holdings, you can compare the effects of market volatilities on 23Andme Holding and Maravai Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Maravai Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Maravai Lifesciences.
Diversification Opportunities for 23Andme Holding and Maravai Lifesciences
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between 23Andme and Maravai is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Maravai Lifesciences Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maravai Lifesciences and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Maravai Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maravai Lifesciences has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Maravai Lifesciences go up and down completely randomly.
Pair Corralation between 23Andme Holding and Maravai Lifesciences
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Maravai Lifesciences. In addition to that, 23Andme Holding is 1.05 times more volatile than Maravai Lifesciences Holdings. It trades about -0.08 of its total potential returns per unit of risk. Maravai Lifesciences Holdings is currently generating about 0.03 per unit of volatility. If you would invest 537.00 in Maravai Lifesciences Holdings on August 27, 2024 and sell it today you would lose (15.00) from holding Maravai Lifesciences Holdings or give up 2.79% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. Maravai Lifesciences Holdings
Performance |
| Timeline |
| 23Andme Holding |
| Maravai Lifesciences |
23Andme Holding and Maravai Lifesciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Maravai Lifesciences
The main advantage of trading using opposite 23Andme Holding and Maravai Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Maravai Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maravai Lifesciences will offset losses from the drop in Maravai Lifesciences' long position.| 23Andme Holding vs. Eliem Therapeutics | 23Andme Holding vs. HCW Biologics | 23Andme Holding vs. Scpharmaceuticals | 23Andme Holding vs. Milestone Pharmaceuticals |
| Maravai Lifesciences vs. Roivant Sciences | Maravai Lifesciences vs. Krystal Biotech | Maravai Lifesciences vs. Akero Therapeutics | Maravai Lifesciences vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |